Literature DB >> 22401342

The need for identifying standardized indices for measuring glucose variability.

Fabiana Picconi, Alessandra Di Flaviani, Ilaria Malandrucco, Ilaria Giordani, Susanna Longo, Simona Frontoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22401342      PMCID： PMC3320842          DOI： 10.1177/193229681200600129

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  6 in total

Review 1.  Measuring glycaemic variation.

Authors:  Fergus J Cameron; Susan M Donath; Peter A Baghurst
Journal:  Curr Diabetes Rev       Date:  2010-01

2.  Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E.

Authors:  Raffaele De Caterina; Francesco Cipollone; Francesca Paola Filardo; Marco Zimarino; Walter Bernini; Guido Lazzerini; Tonino Bucciarelli; Angela Falco; Paola Marchesani; Raffaella Muraro; Andrea Mezzetti; Giovanni Ciabattoni
Journal:  Circulation       Date:  2002-11-12       Impact factor: 29.690

3.  Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry.

Authors:  J Proudfoot; A Barden; T A Mori; V Burke; K D Croft; L J Beilin; I B Puddey
Journal:  Anal Biochem       Date:  1999-08-01       Impact factor: 3.365

4.  No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients.

Authors:  Sarah E Siegelaar; Temo Barwari; Wim Kulik; Joost B Hoekstra; J Hans DeVries
Journal:  J Diabetes Sci Technol       Date:  2011-01-01

Review 5.  Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment.

Authors:  A Giaccari; G Sorice; G Muscogiuri
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-05-09       Impact factor: 4.222

6.  Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.

Authors:  Alessandra Di Flaviani; Fabiana Picconi; Paola Di Stefano; Ilaria Giordani; Ilaria Malandrucco; Paola Maggio; Paola Palazzo; Fabrizio Sgreccia; Carlo Peraldo; Fabrizio Farina; Gaetano Frajese; Simona Frontoni
Journal:  Diabetes Care       Date:  2011-05-24       Impact factor: 19.112
  6 in total
  1 in total

1.  A consensus perceived glycemic variability metric.

Authors:  Cynthia R Marling; Nigel W Struble; Razvan C Bunescu; Jay H Shubrook; Frank L Schwartz
Journal:  J Diabetes Sci Technol       Date:  2013-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.